Collegium Pharmaceutical, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 197
- Market Cap
- $1.2B
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
3
FDA:3
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)
- First Posted Date
- 2012-09-14
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Collegium Pharmaceutical, Inc.
- Target Recruit Count
- 740
- Registration Number
- NCT01685684
News
No news found